Pediatrician perspectives on barriers and facilitators to discharge instruction comprehension and adherence for parents of children with medical complexity.

BACKGROUND: High rates of posthospitalization errors are observed in children with medical complexity (CMC). Poor parent comprehension of and adherence to complex discharge instructions can contribute to errors. Pediatrician views on common barriers and facilitators to parent comprehension and adherence are understudied. OBJECTIVE: To examine pediatrician perspectives on barriers and facilitators experienced by parents in comprehension of and adherence to inpatient discharge instructions for CMC. DESIGN, SETTINGS, AND PARTICIPANTS: We conducted a qualitative, descriptive study of attending pediatricians (n = 20) caring for CMC in inpatient settings (United States and Canada) and belonging to listservs for pediatric hospitalists/complex care providers. We used purposive/maximum variation sampling to ensure heterogeneity (e.g., hospital, region). MAIN OUTCOME AND MEASURES: A multidisciplinary team designed and piloted a semistructured interview guide with pediatricians who care for CMC. Team members conducted semistructured interviews via phone or video call. Interviews were audiorecorded and transcribed. We analyzed transcripts using content analysis; codes were derived a priori from a conceptual framework (based on the Pediatric Self-Management Model) and a preliminary transcript analysis. We applied codes and identified emerging themes. RESULTS: Pediatricians identified three themes as barriers and facilitators to discharge instruction comprehension and adherence: (1) regimen complexity, (2) access to the healthcare team (e.g., inpatient team, outpatient pediatrician, home nursing) and resources (e.g., medications, medical equipment), and (3) need for a family centered and health literacy-informed approach to discharge planning and education. Next steps include the assessment of parent perspectives on barriers and facilitators to discharge instruction comprehension and adherence for prents of CMC and the development of intervention strategies.

Evaluating Large Language Models in Extracting Cognitive Exam Dates and Scores.

Importance: Large language models (LLMs) are crucial for medical tasks. Ensuring their reliability is vital to avoid false results. Our study assesses two state-of-the-art LLMs (ChatGPT and LlaMA-2) for extracting clinical information, focusing on cognitive tests like MMSE and CDR. Objective: Evaluate ChatGPT and LlaMA-2 performance in extracting MMSE and CDR scores, including their associated dates. Methods: Our data consisted of 135,307 clinical notes (Jan 12th, 2010 to May 24th, 2023) mentioning MMSE, CDR, or MoCA. After applying inclusion criteria 34,465 notes remained, of which 765 underwent ChatGPT (GPT-4) and LlaMA-2, and 22 experts reviewed the responses. ChatGPT successfully extracted MMSE and CDR instances with dates from 742 notes. We used 20 notes for fine-tuning and training the reviewers. The remaining 722 were assigned to reviewers, with 309 each assigned to two reviewers simultaneously. Inter-rater-agreement (Fleiss' Kappa), precision, recall, true/false negative rates, and accuracy were calculated. Our study follows TRIPOD reporting guidelines for model validation. Results: For MMSE information extraction, ChatGPT (vs. LlaMA-2) achieved accuracy of 83% (vs. 66.4%), sensitivity of 89.7% (vs. 69.9%), true-negative rates of 96% (vs 60.0%), and precision of 82.7% (vs 62.2%). For CDR the results were lower overall, with accuracy of 87.1% (vs. 74.5%), sensitivity of 84.3% (vs. 39.7%), true-negative rates of 99.8% (98.4%), and precision of 48.3% (vs. 16.1%). We qualitatively evaluated the MMSE errors of ChatGPT and LlaMA-2 on double-reviewed notes. LlaMA-2 errors included 27 cases of total hallucination, 19 cases of reporting other scores instead of MMSE, 25 missed scores, and 23 cases of reporting only the wrong date. In comparison, ChatGPT's errors included only 3 cases of total hallucination, 17 cases of wrong test reported instead of MMSE, and 19 cases of reporting a wrong date. Conclusions: In this diagnostic/prognostic study of ChatGPT and LlaMA-2 for extracting cognitive exam dates and scores from clinical notes, ChatGPT exhibited high accuracy, with better performance compared to LlaMA-2. The use of LLMs could benefit dementia research and clinical care, by identifying eligible patients for treatments initialization or clinical trial enrollments. Rigorous evaluation of LLMs is crucial to understanding their capabilities and limitations.

Ventricular Dysfunction in Obese and Nonobese Rats with Metabolic Syndrome.

Obesity and dyslipidemias are both signs of metabolic syndrome, usually associated with ventricular arrhythmias. Here, we tried to identify cardiac electrical alteration and biomarkers in nonobese rats with metabolic syndrome (MetS), and these findings might lead to more lethal arrhythmias than obese animals. The MetS model was developed in Wistar rats with high-sucrose diet (20%), and after twenty-eight weeks were obtained two subgroups: obese (OMetS) and nonobese (NOMetS). The electrocardiogram was used to measure the ventricular arrhythmias and changes in the heart rate variability. Also, we measured ventricular hypertrophy and its relationship with electrical activity alterations of both ventricles, using micro-electrode and voltage clamp techniques. Also, we observed alterations in the contraction force of ventricles where a transducer was used to record mechanical and electrical papillary muscle, simultaneously. Despite both subgroups presenting long QT syndrome (0.66 ± 0.05 and 0.66 ± 0.07 ms with respect to the control 0.55 ± 0.1 ms), the changes in the heart rate variability were present only in OMetS, while the NOMetS subgroup presented changes in QT interval variability (NOMetS SD = 1.8, SD2 = 2.8; SD1/SD2 = 0.75). Also, the NOMetS revealed tachycardia (10%; p < 0.05) with changes in action potential duration (63% in the right papillary and 50% in the left papillary) in the ventricular papillary which are correlated with certain alterations in the potassium currents and the force of contraction. The OMetS showed an increase in action potential duration and the force of contraction in both ventricles, which are explained as bradycardia. Our results revealed lethal arrhythmias in both MetS subgroups, irrespectively of the presence of obesity. Consequently, the NOMetS showed mechanical-electrical alterations regarding ventricle hypertrophy that should be at the NOMetS, leading to an increase of CV mortality.

Serial Monitoring of Circulating Tumor DNA by Next-Generation Gene Sequencing as a Biomarker of Response and Survival in Patients With Advanced NSCLC Receiving Pembrolizumab-Based Therapy.

Although the majority of patients with metastatic non-small-cell lung cancer (mNSCLC) lacking a detectable targetable mutation will receive pembrolizumab-based therapy in the frontline setting, predicting which patients will experience a durable clinical benefit (DCB) remains challenging. MATERIALS AND METHODS: Patients with mNSCLC receiving pembrolizumab monotherapy or in combination with chemotherapy underwent a 74-gene next-generation sequencing panel on blood samples obtained at baseline and at 9 weeks. The change in circulating tumor DNA levels on-therapy (molecular response) was quantified using a ratio calculation with response defined by a > 50% decrease in mean variant allele fraction. Patient response was assessed using RECIST 1.1; DCB was defined as complete or partial response or stable disease that lasted > 6 months. Progression-free survival and overall survival were recorded. RESULTS: Among 67 patients, 51 (76.1%) had > 1 variant detected at a variant allele fraction > 0.3% and thus were eligible for calculation of molecular response from paired baseline and 9-week samples. Molecular response values were significantly lower in patients with an objective radiologic response (log mean 1.25% v 27.7%, P < .001). Patients achieving a DCB had significantly lower molecular response values compared to patients with no durable benefit (log mean 3.5% v 49.4%, P < .001). Molecular responders had significantly longer progression-free survival (hazard ratio, 0.25; 95% CI, 0.13 to 0.50) and overall survival (hazard ratio, 0.27; 95% CI, 0.12 to 0.64) compared with molecular nonresponders. CONCLUSION: Molecular response assessment using circulating tumor DNA may serve as a noninvasive, on-therapy predictor of response to pembrolizumab-based therapy in addition to standard of care imaging in mNSCLC. This strategy requires validation in independent prospective studies.

Optical mapping of the 22q11.2DS region reveals complex repeat structures and preferred locations for non-allelic homologous recombination (NAHR).

The most prevalent microdeletion in humans occurs at 22q11.2, a region rich in chromosome-specific low copy repeats (LCR22s). The structure of this region has defied elucidation due to its size, regional complexity, and haplotype diversity, and is not well represented in the human genome reference. Most individuals with 22q11.2 deletion syndrome (22q11.2DS) carry a de novo hemizygous deletion of ~ 3 Mbp occurring by non-allelic homologous recombination (NAHR) mediated by LCR22s. In this study, optical mapping has been used to elucidate LCR22 structure and variation in 88 individuals in thirty 22q11.2DS families to uncover potential risk factors for germline rearrangements leading to 22q11.2DS offspring. Families were optically mapped to characterize LCR22 structures, NAHR locations, and genomic signatures associated with the deletion. Bioinformatics analyses revealed clear delineations between LCR22 structures in normal and deletion-containing haplotypes. Despite no explicit whole-haplotype predisposing configurations being identified, all NAHR events contain a segmental duplication encompassing FAM230 gene members suggesting preferred recombination sequences. Analysis of deletion breakpoints indicates that preferred recombinations occur between FAM230 and specific segmental duplication orientations within LCR22A and LCR22D, ultimately leading to NAHR. This work represents the most comprehensive analysis of 22q11.2DS NAHR events demonstrating completely contiguous LCR22 structures surrounding and within deletion breakpoints.

Baseline Plasma Tumor Mutation Burden Predicts Response to Pembrolizumab-based Therapy in Patients with Metastatic Non-Small Cell Lung Cancer.

PURPOSE: The role of plasma-based tumor mutation burden (pTMB) in predicting response to pembrolizumab-based first-line standard-of-care therapy for metastatic non-small cell lung cancer (mNSCLC) has not been explored. EXPERIMENTAL DESIGN: A 500-gene next-generation sequencing panel was used to assess pTMB. Sixty-six patients with newly diagnosed mNSCLC starting first-line pembrolizumab-based therapy, either alone or in combination with chemotherapy, were enrolled (Clinicaltrial.gov identifier: NCT03047616). Response was assessed using RECIST 1.1. Associations were made for patient characteristics, 6-month durable clinical benefit (DCB), progression-free survival (PFS), and overall survival (OS). RESULTS: Of 66 patients, 52 (78.8%) were pTMB-evaluable. Median pTMB was 16.8 mutations per megabase (mut/Mb; range, 1.9-52.5) and was significantly higher for patients achieving DCB compared with no durable benefit (21.3 mut/Mb vs. 12.4 mut/Mb, P = 0.003). For patients with pTMB ≥ 16 mut/Mb, median PFS was 14.1 versus 4.7 months for patients with pTMB < 16 mut/Mb [HR, 0.30 (0.16-0.60); P < 0.001]. Median OS for patients with pTMB ≥ 16 was not reached versus 8.8 months for patients with pTMB < 16 mut/Mb [HR, 0.48 (0.22-1.03); P = 0.061]. Mutations in ERBB2 exon 20, STK11, KEAP1, or PTEN were more common in patients with no DCB. A combination of pTMB ≥ 16 and absence of negative predictor mutations was associated with PFS [HR, 0.24 (0.11-0.49); P < 0.001] and OS [HR, 0.31 (0.13-0.74); P = 0.009]. CONCLUSIONS: pTMB ≥ 16 mut/Mb is associated with improved PFS after first-line standard-of-care pembrolizumab-based therapy in mNSCLC. STK11/KEAP1/PTEN and ERBB2 mutations may help identify pTMB-high patients unlikely to respond. These results should be validated in larger prospective studies.

Same Session Bilateral Ureteroscopy for Multiple Stones: Results from the CROES URS Global Study.

PURPOSE: This study presents a comparison of the international experience with ipsilateral and bilateral ureteroscopy for multiple, bilateral ureteral and renal stones vs single stone treatment. Patient and treatment characteristics and outcomes were compared. MATERIALS AND METHODS: The CROES (Clinical Research Office of the Endourological Society) Ureteroscopy Global Study includes 114 centers in 32 countries. Patients undergoing bilateral ureteroscopy, ipsilateral ureteroscopy for multiple stones and ureteroscopy for a single stone were examined from January 2010 to October 2012. Intraoperative characteristics and postoperative outcomes were identified for each patient. Inverse probability weighted regression adjustment analyses were done to compare outcomes independent of differences among centers and patient characteristics. RESULTS: The CROES Ureteroscopy Global Study consists of 11,885 patients. A total of 2,153 patients (18.7%) were treated for multiple stones, of whom 1,880 (87.3%) and 273 (12.7%) underwent ipsilateral and bilateral ureteroscopy, respectively. Inverse probability weighted regression adjustment models for bilateral vs ipsilateral ureteroscopy and multiple vs single stone treatments showed that patients with bilateral ureteroscopy and multiple stone treatments had lower stone-free rates, higher re-treatment rates and longer operative times compared to patients who underwent ipsilateral ureteroscopy and single stone treatment. There was no difference in complication rates among bilateral, ipsilateral and single stone ureteroscopy. CONCLUSIONS: This study presents a large series of patients who underwent bilateral and ipsilateral ureteroscopy. Our findings suggest a decrease in stone-free rates, increased re-treatment rates, increased operative times and longer hospital stay in patients treated for multiple stones. The treatment of multiple stones and bilateral ureteroscopy are safe compared to single stone treatment and ipsilateral ureteroscopy, respectively.

Trigeminal Neuralgia due to Vertebrobasilar Dolichoectasia.

We presented a case of drug-resistant trigeminal neuralgia attributed to vertebrobasilar dolichoectasia, a rare condition characterized by enlargement, tortuosity, or elongation of intracranial arteries. Dolichoectatic vessels can cause dysfunction of cranial nerves through direct vascular compression. The relationships of vertebrobasilar dolichoectasia with the particularities of neurovascular conflict and images findings are discussed.

Linfoma testicular: incidencia, descripción epidemiológica y manejo durante el período 2005-2011 / Testicular lymphoma: incidence, epidemiologic description and management during the 2005-2011 period

El linfoma testicular es una patología infrecuente, correspondiendo al 9 por ciento de los cánceres testiculares, presentándose más frecuentemente entre los 60 a 80 años (25-50 por ciento). La presentación clínica más frecuente es el aumento de volumen unilateral e indo/oro. El tipo histológico más común es linfoma difuso de células grandes B (60-90 por ciento). La orquidectomía radical asociada a quimioterapia y radioterapia es la primera línea de tratamiento para los pacientes con enfermedad limitada. Material y método: Estudio retrospectivo descriptivo. Se revisó y filtró la lista de pacientes ingresados al SIGGES como tumor testicular entre enero 2005 a abril 2011. De los pacientes con diagnóstico histológico e inmunohistoquímico compatible, se registraron las características epidemiológicas, estudio, manejo y sobrevida. Posteriormente se realizó un análisis de la base de datos con el programa estadístico SPSS 13. 0. Resultados: De un total de 299 pacientes con el diagnóstico histológico de cáncer testicular, 8 pacientes fueron diagnosticados como linfoma testicular confirmado por histología e inmunohistoquímica. El promedio y mediana de edad fue 52 años y 63 años (18-73) respectivamente. Tres casos (37,5 por ciento) correspondieron a presentaciones secundarias. En 6 de los casos (75 por ciento) el testículo afectado fue el derecho. Histológicamente, el 63 por ciento correspondió a Linfoma difuso de células grande B. Clínicamente, el todos los casos se presentaron con aumento de volumen y con marcadores en rango normal. En 7 casos (8 7, 5 por ciento) el diagnóstico y manejo inicial fue mediante orquidectomía radical, y en un caso por biopsia testicular, con orquidectomía posterior 3 casos presentaron diseminación...

esticular lymphoma is a rare disease, happening in 9 percent of testicular cancers, most commonly between the ages 60 to 80 years (25 percent-50 percent). The most common presentation is unilateral indolent testicular growth. Histology shows a diffuse big B cell lymphoma in most of the cases (60 percent-90 percent). Radical orchiectomy, chemotherapy and radiation are the first line therapy for patients with limited disease. Materials and methods: Retrospective clinical study. We included and filtered the SIGGES list of patients admitted for Testicular Tumor from January 2005 to April 2011. Patients with a compatible diagnosis were analyzed, using SPSS 13.0® as statistical software. Result: Of a total number of 299 testicular cancer patients 8 presented with a histological and inmunnohistochemical testicular lymphoma. Mean age was 52 years and the median 63 years (18-73). ln three cases (37.5 percent) it was a secondary localization. ln 6 cases ( 75 percent) the affected testicle was the right one. 63 percent corresponded to a diffuse big cell B cell Lymphoma. All patients presented normal tumor markers. ln 7 (87,5 percent) cases the initial treatment was radical orchiectomy in one patient the diagnosis was don through a testicular biopsy, and the orchidectomy was differed. 3 cases presented dissemination. In 7 patients adjuvant chemotherapy was performed. Mortal/ty was 38 percent with a 1 7-month follow-up. Conclusion: Testicular lymphoma is a rare condition with bad prognosis. Histology is fundamental for treatment, an in this sense inmunohystochemcal analysis is especially helpful...

Cirugía percutánea renal bilateral simultánea en decúbito supino: experiencia inicial / Percutaneous bilateral renal surgery in supine position: initial experience

La litiasis renal bilateral voluminosa es un desafío quirúrgico para el endourólogo. La cirugía percutánea bilateral simultánea (CPRBS) es una modalidad aceptada, tanto en adultos como niños, sin embargo existe poca literatura al respecto. Presentamos nuestra experiencia de 3 pacientes (6 unidades renales) en posición de Valdivia-Galdakao. Incluimos el primer reporte mundial de un caso de CPRBS tubeless bilateral en de cúbito supino...

Simultaneous bilateral PCNL (SBPCNL) is a safe procedure and can be used effectively in adults as well as in children. In addition to being cost effective, it involves only a single anesthesia with a shorter hospital stay and faster convalescence. We present our initial experience of 3 cases (6 renal units) in supine position. We include the first report to our knowledge of a tubeless SBPCNL in supine position...

Spinal intradural arteriovenous fistula mimicking intramedullary tumor and associated with a giant intracranial aneurysm / Fístula arteriovenosa intradural espinhal mimetizando tumor intramedular e associado com aneurisma intracraniano gigante

Spinal intradural arteriovenous fistulas (AVFs) are a rare type of neurovascular malformation. Many a time hemodynamic disturbs associated to these entities can cause edema with subsequent myelopathy. On MRI study, this edema can mimic an intramedullary tumor. We report a rare case of spinal intradural AVFs mimicking an intramedullary tumor, which also were surprisingly associated with a giant intracranial aneurysm. We highlight in detail the MRI findings in intramedullary lesions, and also emphasize that these entities requires as careful differential diagnosis as supplementary investigation of the neuroaxis looking for other simultaneous neurovascular pathologies.

Fístulas arteriovenosas espinhais intradurais são um tipo raro de malformação neurovascular. Muitas vezes, distúrbios hemodinâmicos associados a essa entidade podem causar edema com subsequente mielopatia. Em estudos de ressonância magnética, esse edema pode mimetizar um tumor intramedular. Relata-se um caso raro de fistula arteriovenosa espinhal intradural mimetizando um tumor intramedular, que também estava associado a um aneurisma cerebral gigante. Destacam-se em detalhes os achados de RM nas lesões intramedulares, assim como se enfatiza que essas entidades requerem tanto um diagnóstico diferencial criterioso quanto uma investigação complementar do neuroeixo procurando por outras patologias neurovasculares associadas.

The anatomy of the callosomarginal artery: applications to microsurgery and endovascular surgery.

BACKGROUND: The callosomarginal artery (CMA), the main branch of the pericallosal artery, courses in or near the cingulate sulcus and gives rises to 2 or more major cortical branches. There is confusion about the artery best fitting the definition of "callosomarginal artery." Distal anterior cerebral artery aneurysms represent 1.5% to 9% of intracranial aneurysms, and most often occur at the origin of the CMA. The microsurgical anatomic features of the CMA, its relationship with the pericallosal artery, and clinical implications are presented. METHODS: The origin, course, branching pattern, and diameter of the CMA and its branches and its relationship with the pericallosal artery were studied in 60 cerebral hemispheres, including cadaveric dissections and angiographic images. RESULTS: The CMA was present in 93.3% of hemispheres studied and arose mainly from A3 (55.2%), a mean of 3.11 +/- 1.90 cm from the anterior communicating artery. The mean diameter of the CMA at its origin was 1.53 +/- 0.36 mm. The CMA ran 1.28 +/- 0.89 cm until its first branch, describing an anterior convex curve backward and upward (60.7%). An average of 3 lesser branches originated from the CMA. The most consistent branch was the posterior internal frontal artery (67.9%). The mean diameter of the CMA branches was 0.93 +/- 0.33 mm. CONCLUSION: These morphometric measurements can help neurosurgeons access lesions located in distal intracranial vessels. The vessel coursing the longest pathway in or near the cingulate sulcus and otherwise following Moscow's classic definition should be considered the CMA.

¿Es necesario el enema rectal en la biopsia de próstata? / Is it necessary to perform rectal enema for prostate biopsies?

Nuestro objetivo fue evaluar la necesidad real de enema rectal previo a la realización de biopsia prostática y su implicación en posibles complicaciones infecciosas asociadas al procedimiento. Material y Métodos. Entre Enero y Junio del 2006, 128 pacientes recibieron biopsia prostática. Fueron asignados a dos grupos, recibiendo o no enema rectal. De estos, 90 pacientes presentaron información evaluable y constituyeron la población de estudio. Resultados. No se verificaron diferencias significativas entre los dos grupos de estudio. Conclusiones. El presente trabajo demuestra la utilidad limitada que tiene el enema rectal previo a biposia prostática.

We aimed to evaluate the real usefulness of rectal enema previous to transrectal prostatic biopsy and its possible implications in infectious complications. Methods. Between January and June 2006, 128 consecutive patients underwent transrectal prostatic biopsy at our institution. Patients were assigned to two groups’ receiving rectal enema or not. Of these, 90 patient shad complete available information and constituted the population of study. Results. No significant differences were verified between the two groups of study. Conclusions. Present manuscript shows the limited usefulness of rectal enema previous a transrectal prostate biopsy.

Experiencia con dos técnicas de cinta suburetral libre de tensión: vaginal y suprapúbica / Experience with two free tension subureteral ribbon techniques: vaginal and suprapubic

El tratamiento quirúrgico de la incontinencia de orina en la mujer cambió desde el desarrollodel Modelo de la Teoría Integral. A partir del año 1994, la técnica de cinta vaginal libre de tensión, conel uso de malla de polipropileno (Prolene) se ha masificado progresivamente. Existen diferentes abordajespara la instalación de la cinta suburetral. Presentamos nuestra experiencia y una comparación de latécnica suprapúbica con la técnica por vía vaginal. Material y método: Revisión retrospectiva de laspacientes sometidas a cirugía por incontinencia de orina con cinta suburetral libre de tensión. En 2 años,se intervinieron 55 pacientes. Se tabularon datos generales, relacionados con la anamnesis, incluyendoparidad y de corrección de incontinencia previas; valores de estudios urodinámicos, detalles de la intervención,y anamnesis postoperatoria inmediata y tardía. Resultados: Se constituyeron 2 grupos: grupovía suprapúbica (SP) de 29 pacientes y el grupo por vía vaginal (V) de 26 mujeres. La edad promedio fuede 59 y 62 años, paridad de 2,3 y 3,3 y la incidencia de IOE+IOM fue de 96 por ciento y 93 por ciento, respectivamente. Latasa de cirugía previa anti-incontinencia fue significativamente mayor en grupo SP (38 por ciento versus 7 por ciento). Eltiempo operatorio promedio en grupo SP y grupo V fue de 54 y 53 minutos, la permanencia de catétervesical fue de 41 y 38 horas. La recidiva de la IO se presentó en una paciente del grupo SP (3,4 por ciento) yninguna del grupo V. La sobrecorrección de la IO se presentó en una paciente de cada grupo, ambasatribuibles a edema perioperatorio. Una paciente del grupo SP presentó perforación uretral. El 41 por ciento (12pacientes) del grupo SP tuvo perforación vesical y ninguna del grupo V, todas con manejo conservador.Una paciente del grupo V presentó erosión de la uretra con paso de la cinta al lumen uretral. El seguimientofue de 16 y 12 meses en promedio, para el grupo SP y V, respectivamente. De las 12 pacientes conperforació

Valorizacion de Rhus toxicodendron y ciclosporina A, a dosis homeopaticas en transplante de piel en ratones / The effects of Rhus toxicodendron and Ciclosporina A, in homeopathic dosage, in skin transplantation in mices

Se tomaron 40 ratones hembas de raza CDI y otros de una mezcla CD4, NDI y C57, y se hicieron 5 grupos: 1. 10 animales testigo con injerto de piel de la misma especie, de diferente animal, sin medicamento. 2. 5 testigos con autoinjerto, piel del mismo individuo, sin medicamento. 3. 5 testigos a los cuales se les quito una porcion de piel sin ponerseles nada para valorar diferencias de cicatrizacion, en relacion con los que rechazaron el transplante. 4. 10 ratones con tranplante de piel "aloinjerto u homoinjerto", tratados con Rhus tox. a la 30c. 5. 10 animales con transplante de piel "aloinjerto u homoinjerto", tratados con Ciclosporina A a la 30 c. Los medicamentos se proporcionaron en el agua de uso a razon de 2ml por cada 100 ml durante tres semanas; se suspendieron tres semanas y se volvieron a proporcionar durante dos semanas mas y a lo largo de todo el experimento. Resultados: El grupo 4 de animales tratados con Rhus tox. no dio datos significativos en relacion con los testigos que rechazaron en 10.6 dias promedio. El grupo 5 de ratones tratados con Ciclosporina A rechazaron en 4.8 dias con necrosis y edema, por lo que se comprobo el efecto contrario, aumentando la inmunidad en dosis homeopaticas, ya que cuando se proporciona la Ciclosporina A a dosis alopaticas provoca una inmunosupresion que ocasiona tolerancia a los trasplantes de tejidos

Valorizacion de Rhus toxicodendron y ciclosporina A, a dosis homeopaticas en transplante de piel en ratones / The effects of Rhus toxicodendron and Ciclosporina A, in homeopathic dosage, in skin transplantation in mices

Se tomaron 40 ratones hembas de raza CDI y otros de una mezcla CD4, NDI y C57, y se hicieron 5 grupos: 1. 10 animales testigo con injerto de piel de la misma especie, de diferente animal, sin medicamento. 2. 5 testigos con autoinjerto, piel del mismo individuo, sin medicamento. 3. 5 testigos a los cuales se les quito una porcion de piel sin ponerseles nada para valorar diferencias de cicatrizacion, en relacion con los que rechazaron el transplante. 4. 10 ratones con tranplante de piel "aloinjerto u homoinjerto", tratados con Rhus tox. a la 30c. 5. 10 animales con transplante de piel "aloinjerto u homoinjerto", tratados con Ciclosporina A a la 30 c. Los medicamentos se proporcionaron en el agua de uso a razon de 2ml por cada 100 ml durante tres semanas; se suspendieron tres semanas y se volvieron a proporcionar durante dos semanas mas y a lo largo de todo el experimento. Resultados: El grupo 4 de animales tratados con Rhus tox. no dio datos significativos en relacion con los testigos que rechazaron en 10.6 dias promedio. El grupo 5 de ratones tratados con Ciclosporina A rechazaron en 4.8 dias con necrosis y edema, por lo que se comprobo el efecto contrario, aumentando la inmunidad en dosis homeopaticas, ya que cuando se proporciona la Ciclosporina A a dosis alopaticas provoca una inmunosupresion que ocasiona tolerancia a los trasplantes de tejidos